eMedicine Specialties > General Surgery > Abdomen

Abdominal Angina

Author: Faisal Aziz, MD,, Vascular Surgery Fellow, Jobst Vascular Center, Ohio
Coauthor(s): Anthony J Comerota, MD, FACS, FRACS(HON), FACC, Section Head of Vascular Surgery, Department of Surgery, Director of Jobst Vascular Center, Program Director of General Vascular Surgery Residency, Toledo Hospital; Director of Jobst (ProMedica)Vascular Laboratories; Adjunct Professor of Surgery, Department of Surgery, University of Michigan
Contributor Information and Disclosures

Updated: Dec 3, 2009

Introduction

Background

Abdominal angina is defined as the postprandial pain that occurs in individuals with sufficient mesenteric vascular occlusive disease such that blood flow cannot increase enough to meet visceral demands. The mechanism is believed to be similar to the angina pectoris that occurs in individuals with coronary artery disease or the intermittent claudication that accompanies peripheral vascular disease, as depicted in the image below.

The superior mesenteric artery and inferior mesen...

The superior mesenteric artery and inferior mesenteric artery share collateral circulation near the splenic flexure of the colon. When dilated, this vessel is termed the meandering mesenteric artery. As seen on an angiogram, this is a sign of chronic mesenteric ischemia.

The superior mesenteric artery and inferior mesen...

The superior mesenteric artery and inferior mesenteric artery share collateral circulation near the splenic flexure of the colon. When dilated, this vessel is termed the meandering mesenteric artery. As seen on an angiogram, this is a sign of chronic mesenteric ischemia.


The pancreaticoduodenal arcades are collateral pa...

The pancreaticoduodenal arcades are collateral pathways between the celiac artery and the superior mesenteric artery.

The pancreaticoduodenal arcades are collateral pa...

The pancreaticoduodenal arcades are collateral pathways between the celiac artery and the superior mesenteric artery.


Although Schnitzler first described the clinical picture of postprandial clinical pain in 1901, description of the syndrome of postprandial abdominal angina generally is attributed to Baccelli or Goodman (1918). In 1936, Dunphy recognized that this syndrome was a precursor of fatal intestinal necrosis; however, not until 1957 did Mikkelsen propose surgical treatment of occlusive mesenteric vascular disease. Shaw and Maynard reported the first transarterial thromboendarterectomy of the superior mesenteric artery (SMA) in 1958, followed in rapid succession by Mikkelsen and Zarro in 1959. Numerous technical refinements followed.

Pathophysiology

Intestinal ischemia results from the mismatch of oxygen supply to and oxygen consumption by the gastrointestinal tract owing to reduced blood flow. The decreased blood flow results from narrowing of the mesenteric vessels, which can be can be secondary to a thrombus or embolus. The most common cause of abdominal angina is atherosclerotic vascular disease. The occlusive process commonly involves the ostia and a few proximal centimeters of the mesenteric vessels. Aortoiliac occlusive disease frequently coexists and may be the cause of the ostial lesions.

The 3 arteries supplying the gut are the celiac, superior mesenteric, and inferior mesenteric, as shown below. Unless significant stenoses or actual occlusion of 2 of the 3 vessels is present, efficient collateral circulation between the celiac and superior mesenteric arteries (ie, the pancreaticoduodenal arcades) and the superior and inferior mesenteric arteries (ie, the meandering mesenteric artery) ensures that blood flow to the gut generally is adequate. The internal iliac arteries also may be an important source of collateral hindgut and midgut perfusion in the presence of inferior mesenteric arterial occlusion.

The superior mesenteric artery and inferior mesen...

The superior mesenteric artery and inferior mesenteric artery share collateral circulation near the splenic flexure of the colon. When dilated, this vessel is termed the meandering mesenteric artery. As seen on an angiogram, this is a sign of chronic mesenteric ischemia.

The superior mesenteric artery and inferior mesen...

The superior mesenteric artery and inferior mesenteric artery share collateral circulation near the splenic flexure of the colon. When dilated, this vessel is termed the meandering mesenteric artery. As seen on an angiogram, this is a sign of chronic mesenteric ischemia.


The pancreaticoduodenal arcades are collateral pa...

The pancreaticoduodenal arcades are collateral pathways between the celiac artery and the superior mesenteric artery.

The pancreaticoduodenal arcades are collateral pa...

The pancreaticoduodenal arcades are collateral pathways between the celiac artery and the superior mesenteric artery.


SMA occlusion almost invariably is observed in patients with symptomatic occlusive mesenteric ischemia. Theories suggest that, because the SMA provides vascularity to the foregut, midgut, and hindgut, collaterals cannot sufficiently compensate for occlusion of this central artery.

Within 15 minutes of eating, duplex Doppler studies can show increased blood flow in the celiac and superior mesenteric vessels in healthy volunteers. Patients with abdominal angina are unable to sufficiently increase flow in the mesenteric vessels, and ischemic pain results. Affected individuals learn to associate food with pain, and thus, they develop a fear of eating. Weight loss may be significant.

Median arcuate ligament syndrome is thought to be a syndrome of abdominal pain caused by compression of the celiac trunk by the median arcuate ligament and, perhaps, by dense encasement by periarterial neural tissue. Described in 1965 by Dunbar and colleagues, compression of the celiac artery is thought to cause intimal fibrosis that leads to luminal stenosis and impaired splanchnic blood flow. This would result in symptoms similar to those of atherosclerotic mesenteric ischemia, which nearly always is caused by at least 2 major visceral artery occlusive lesions. In patients with median arcuate ligament syndrome, symptoms may be a result of compression of a single visceral artery in the absence of adequate collaterals; mesenteric steal or neurogenic mechanisms also have been proposed as causes. Symptoms have been reported to be provoked by exercise in isolated cases.

Definitive corroboration of any of these explanations is lacking, hence the controversial nature of the condition. Further discussion of this topic exceeds the scope of this article, but interested readers may refer to related references in the bibliography.

Frequency

International

The syndrome is extremely rare, and the true incidence is unknown.

Mortality/Morbidity

Despite advances in surgery, the mortality rate associated with acute mesenteric ischemia ranges from 60-95%. 1

Race

No data are available regarding the relative incidence among different races.

Sex

In contrast to the usual male predilection of atherosclerotic vascular disease, in most series, females outnumber males by approximately 3 to 1.

Age

The mean age of affected individuals is slightly older than 60 years. Median arcuate ligament syndrome (see Pathophysiology above) has been reported in young individuals.

Clinical

History

  • The classic description of intestinal angina is abdominal pain that is out of proportion with physical examination.
  • The hallmark of this condition is disabling midepigastric or central abdominal pain that develops 10-15 minutes after eating.
    • The pain gradually increases in intensity, reaches a plateau, and then slowly decreases in intensity several hours after eating.
    • Initially, this pain pattern develops only after large meals, but as the disease progresses, even small meals may be poorly tolerated.
  • Some patients have associated motility disturbances such as diarrhea or constipation, bloating, or vomiting.
  • The pain is poorly localized and described as cramplike or a dull ache. Occasionally, a patient may have constant or intermittent pain that occurs without a clear temporal relationship to eating.
  • Soon, patients associate eating with pain and develop a characteristic fear of food (ie, sitophobia) or food-avoidance behavior. In several clinical series, reported weight loss averages 15-25 lb.
  • The constellation of abdominal pain, weight loss, and an average age of 60 years commonly leads to a presumed diagnosis of malignancy and a protracted workup. Because none of the usual contrast studies or endoscopies performed in the course of a workup for malignancy are diagnostic, considerable delay in diagnosis typically results. In several series, the reported delay averages 16-18 months.
  • If patients have multiple risk factors for atherosclerotic occlusive disease, a heightened clinical suspicion for this diagnosis shortens the typical delay in diagnosis.
  • A history of peripheral vascular disease is common. As with other vasculopathies, individuals who smoke predominate in all series.
  • Although diabetes occurs in all series, it is uncommon in patients with this syndrome (in contrast to most other vascular problems).
  • Occasionally, a patient presents with a duodenal or gastric ulcer (which may be Helicobacter pylori negative) or with ischemic colitis.
  • Ischemic pancreatitis also may occur and is associated with epigastric pain. Laboratory studies reveal mildly elevated amylase and lipase. Steatorrhea may be observed.

Physical

  • Physical examination reveals stigmata of weight loss. The abdomen typically is scaphoid and soft, even during an episode of pain.
  • In one series, approximately 10% of patients had positive test results for guaiac.
  • Abdominal bruit is present in 60-90% of patients, but this is common in many elderly persons who are not affected by this syndrome.
  • Signs of peripheral vascular disease, particularly aortoiliac occlusive disease, may be present.

Causes

  • Smoking is an associated risk factor. In most series, approximately 75-80% of patients smoke.

More on Abdominal Angina

Overview: Abdominal Angina
Differential Diagnoses & Workup: Abdominal Angina
Treatment & Medication: Abdominal Angina
Follow-up: Abdominal Angina
Multimedia: Abdominal Angina
References
Further Reading

References

  1. Schoots IG, Koffeman GI, Legemate DA, Levi M, van Gulik TM. Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg. Jan 2004;91(1):17-27. [Medline].

  2. Danse EM, Kartheuser A, Paterson HM, et al. Color Doppler sonography of small bowel wall changes in 21 consecutive cases of acute mesenteric ischemia. JBR-BTR. Jul-Aug 2009;92(4):202-6. [Medline].

  3. Pellerito JS, Revzin MV, Tsang JC, et al. Doppler sonographic criteria for the diagnosis of inferior mesenteric artery stenosis. J Ultrasound Med. May 2009;28(5):641-50. [Medline].

  4. Cunningham CG, Reilly LM, Rapp JH, Schneider PA, Stoney RJ. Chronic visceral ischemia. Three decades of progress. Ann Surg. Sep 1991;214(3):276-87; discussion 287-8. [Medline][Full Text].

  5. Thomas JH, Blake K, Pierce GE, et al. The clinical course of asymptomatic mesenteric arterial stenosis. J Vasc Surg. May 1998;27(5):840-4. [Medline].

  6. Schermerhorn ML, Giles KA, Hamdan AD, et al. Mesenteric revascularization: management and outcomes in the United States, 1988-2006. J Vasc Surg. Aug 2009;50(2):341-348.e1. [Medline].

  7. Aksu C, Demirpolat G, Oran I, et al. Stent implantation in chronic mesenteric ischemia. Acta Radiol. Jul 2009;50(6):610-6. [Medline].

  8. Moschetta M, Stabile Ianora AA, Pedote P, et al. Prognostic value of multidetector computed tomography in bowel infarction. Radiol Med. Aug 2009;114(5):780-91. [Medline].

  9. Sarac TP, Altinel O, Kashyap V, Bena J, Lyden S, Sruvastava S, et al. Endovascular treatment of stenotic and occluded visceral arteries for chronic mesenteric ischemia. J Vasc Surg. Mar 2008;47(3):485-91. [Medline].

  10. Cho JS, Carr JA, Jacobsen G, et al. Long-term outcome after mesenteric artery reconstruction: a 37-year experience. J Vasc Surg. Mar 2002;35(3):453-60. [Medline].

  11. Cognet F, Ben Salem D, Dranssart M, et al. Chronic mesenteric ischemia: imaging and percutaneous treatment. Radiographics. Jul-Aug 2002;22(4):863-79; discussion 879-80. [Medline][Full Text].

  12. Dalman RL, Li KC, Moon WK, Chen I, Zarins CK. Diminished postprandial hyperemia in patients with aortic and mesenteric arterial occlusive disease. Quantification by magnetic resonance flow imaging. Circulation. Nov 1 1996;94(9 Suppl):II206-10. [Medline].

  13. Desmond CP, Roberts SK. Exercise-related abdominal pain as a manifestation of the median arcuate ligament syndrome. Scand J Gastroenterol. Dec 2004;39(12):1310-3. [Medline].

  14. Dordoni L, Tshomba Y, Giacomelli M, Jannello AM, Chiesa R. Celiac artery compression syndrome: successful laparoscopic treatment-a case report. Vasc Endovascular Surg. Jul-Aug 2002;36(4):317-21. [Medline].

  15. English WP, Pearce JD, Craven TE, Edwards MS, Geary RL, Plonk GW, et al. Chronic visceral ischemia: symptom-free survival after open surgical repair. Vasc Endovascular Surg. Nov-Dec 2004;38(6):493-503. [Medline].

  16. Fidelman N, Wilson MW, Boddington S, Knoess N, Lutz J, Wolanske KA, et al. Postoperative evaluation of complex aortovisceral and aortorenal reconstructions by magnetic resonance angiography. Acad Radiol. Sep 2004;11(9):1055-8. [Medline].

  17. Flinn WR, Rizzo RJ, Park JS, Sandager GP. Duplex scanning for assessment of mesenteric ischemia. Surg Clin North Am. Feb 1990;70(1):99-107. [Medline].

  18. Harward TRS. Chronic mesenteric arterial insufficiency: bypass or endarterectomy?. Adv Vasc Surg. 1996;4:109-29.

  19. Johnston KW, Lindsay TF, Walker PM, Kalman PG. Mesenteric arterial bypass grafts: early and late results and suggested surgical approach for chronic and acute mesenteric ischemia. Surgery. Jul 1995;118(1):1-7. [Medline].

  20. Kihara TK, Blebea J, Anderson KM, Friedman D, Atnip RG. Risk factors and outcomes following revascularization for chronic mesenteric ischemia. Ann Vasc Surg. Jan 1999;13(1):37-44. [Medline].

  21. Kolkman JJ, Mensink PB, van Petersen AS, Huisman AB, Geelkerken RH. Clinical approach to chronic gastrointestinal ischaemia: from 'intestinal angina' to the spectrum of chronic splanchnic disease. Scand J Gastroenterol Suppl. 2004;(241):9-16. [Medline].

  22. Leke MA, Hood DB, Rowe VL, Katz SG, Kohl RD, Weaver FA. Technical consideration in the management of chronic mesenteric ischemia. Am Surg. Dec 2002;68(12):1088-92. [Medline].

  23. Maspes F, Mazzetti di Pietralata G, Gandini R, Innocenzi L, Lupattelli L, Barzi F, et al. Percutaneous transluminal angioplasty in the treatment of chronic mesenteric ischemia: results and 3 years of follow-up in 23 patients. Abdom Imaging. Jul-Aug 1998;23(4):358-63. [Medline].

  24. Montalbano JM, Lee FT Jr, Grist TM, Rappe AH, Weiss JW, Kelcz F, et al. Magnetic resonance imaging detection of extraluminal enterally administered gadopentetate dimeglumine in a rat model of intestinal ischemia. Acad Radiol. Jun 1996;3(6):486-92. [Medline].

  25. Nyman U, Ivancev K, Lindh M, Uher P. Endovascular treatment of chronic mesenteric ischemia: report of five cases. Cardiovasc Intervent Radiol. Jul-Aug 1998;21(4):305-13. [Medline].

  26. Park WM, Cherry KJ Jr, Chua HK, Clark RC, Jenkins G, Harmsen WS, et al. Current results of open revascularization for chronic mesenteric ischemia: a standard for comparison. J Vasc Surg. May 2002;35(5):853-9. [Medline].

  27. Pereles FS, Baskaran V. Abdominal magnetic resonance angiography: principles and practical applications. Top Magn Reson Imaging. Oct 2001;12(5):317-26. [Medline].

  28. Razavi M, Chung HH. Endovascular management of chronic mesenteric ischemia. Tech Vasc Interv Radiol. Sep 2004;7(3):155-9. [Medline].

  29. Reilly LM, Ammar AD, Stoney RJ, Ehrenfeld WK. Late results following operative repair for celiac artery compression syndrome. J Vasc Surg. Jan 1985;2(1):79-91. [Medline].

  30. van Bockel JH, Geelkerken RH, Wasser MN. Chronic splanchnic ischaemia. Best Pract Res Clin Gastroenterol. Feb 2001;15(1):99-119. [Medline].

  31. van Wanroij JL, van Petersen AS, Huisman AB, Mensink PB, Gerrits DG, Kolkman JJ, et al. Endovascular treatment of chronic splanchnic syndrome. Eur J Vasc Endovasc Surg. Aug 2004;28(2):193-200. [Medline].

  32. Williams S, Gillespie P, Little JM. Celiac axis compression syndrome: factors predicting a favorable outcome. Surgery. Nov 1985;98(5):879-87. [Medline].

  33. Wolf YG, Verstandig A, Sasson T, Eidelman L, Anner H, Berlatzky Y. Mesenteric bypass for chronic mesenteric ischaemia. Cardiovasc Surg. Feb 1998;6(1):34-41. [Medline].

  34. Wolfman D, Bluth EI, Sossaman J. Median arcuate ligament syndrome. J Ultrasound Med. Dec 2003;22(12):1377-80. [Medline].

Further Reading

Clinical guidelines:
ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). American College of Cardiology Foundation - Medical Specialty Society
American Heart Association - Professional Association
Society for Cardiovascular Angiography and Interventions - Medical Specialty Society
Society for Vascular Medicine and Biology - Medical Specialty Society
Society for Vascular Surgery - Medical Specialty Society
Society of Interventional Radiology - Medical Specialty Society. 2005. 191 pages. NGC:004740

Clinical trials:
Biomagnetic Signals of Intestinal Ischemia

Biomagnetic Signals of Intestinal Ischemia II (SQUID)

Keywords

abdominal angina, mesenteric ischemia, arteriotomy, superior mesenteric artery, celiac artery, intestinal angina, acute mesenteric ischemia, inferior mesenteric artery, postprandial abdominal angina, occlusive mesenteric vascular disease, postprandial pain, symptomatic occlusive mesenteric ischemia, central abdominal pain

Contributor Information and Disclosures

Author

Faisal Aziz, MD,, Vascular Surgery Fellow, Jobst Vascular Center, Ohio
Faisal Aziz, MD, is a member of the following medical societies: American College of Surgeons and American Medical Association
Disclosure: Nothing to disclose.

Coauthor(s)

Anthony J Comerota, MD, FACS, FRACS(HON), FACC, Section Head of Vascular Surgery, Department of Surgery, Director of Jobst Vascular Center, Program Director of General Vascular Surgery Residency, Toledo Hospital; Director of Jobst (ProMedica)Vascular Laboratories; Adjunct Professor of Surgery, Department of Surgery, University of Michigan
Anthony J Comerota, MD, FACS, FRACS(HON), FACC is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Chest Physicians, American College of Surgeons, American Heart Association, American Stroke Association, American Surgical Association, American Venous Forum, Association for Academic Surgery, Eastern Vascular Society, Society for Clinical Vascular Surgery, Society for Vascular Surgery, and Society of University Surgeons
Disclosure: BMS Honoraria Speaking and teaching; BMS Consulting fee Consulting; BMS Grant/research funds None; Covidien Honoraria Speaking and teaching; Covidien Consulting fee Consulting; Otsuka Honoraria Speaking and teaching; Sanofi/Aventis  Speaking and teaching; Sanofi/Aventis Consulting fee Consulting; Sanofi/Aventis Grant/research funds None; Servier Honoraria Speaking and teaching

Medical Editor

Marc D Basson, MD, PhD, MBA, Professor, Chair, Department of Surgery, Michigan State University
Marc D Basson, MD, PhD, MBA is a member of the following medical societies: American College of Surgeons and American Gastroenterological Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

David L Morris, MD, PhD, Professor, Department of Surgery, St George Hospital, University of New South Wales, Australia
Disclosure: RFA Medical None Director; MRC Biotec None Director

CME Editor

Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.

Chief Editor

John Geibel, MD, DSc, MA, Vice Chairman, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital
John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract
Disclosure: AMGEN Royalty Other

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.